[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Clinical Expertise

  • Acute Myeloid Leukemia

About

Dr. John F. DiPersio, Deputy Director, Alvin J. Siteman Cancer Center and Chief of the Division of Oncology at Washington University School of Medicine in St. Louis and the Virginia E. and Samuel J. Golman Professor of Medicine.

Dr. DiPersio’s research focuses on fundamental and translational aspects of leukemia and stem cell biology. These studies include identification of genetic abnormalities in human leukemias, understanding processes involving stem cell and leukemia cell trafficking, and clinical and translational programs in both leukemia/myelodysplastic syndrome and transplantation immunology.

Among his many accomplishments, Dr. DiPersio was instrumental in developing a drug called plerixafor and ruxolitnib in 2019 that were approved by the U.S. Food and Drug Administration in 2008 and 2019 respectively for the treatment of multiple myeloma, non-Hodgkin’s lymphoma and graft versus host disease.

Location

Washington University School Of Medicine: 660 S Euclid Ave, St. Louis, MO 63110, USA

newsletter icon

Get the latest thought leadership on your Blood Cancer delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.